Find therapies in clinical trials near you – page 186

Study of Venetoclax, Ibrutinib, and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia

Study of Venetoclax, Ibrutinib, and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia

Study on Preoperative Chemoradiotherapy with Capecitabine and Temozolomide for Patients with Locally Advanced Rectal Cancer

Study on Cannabidiol and Dronabinol for Children with Refractory Epilepsy

Study on Cannabidiol and Dronabinol for Children with Refractory Epilepsy

Study on Preventing Liver Recurrence in Patients with Intrahepatic Cholangiocarcinoma Using Floxuridine via Hepatic Arterial Infusion Pump

Study on Preventing Liver Recurrence in Patients with Intrahepatic Cholangiocarcinoma Using Floxuridine via Hepatic Arterial Infusion Pump

Study on Metformin for Patients with Esophageal Cancer to Enhance Chemoradiotherapy Response

Study on Metformin for Patients with Esophageal Cancer to Enhance Chemoradiotherapy Response

Study of HM15912 for Adults with Short Bowel Syndrome-associated Intestinal Failure

Study of HM15912 for Adults with Short Bowel Syndrome-associated Intestinal Failure

Study on the Effects of Siponimod for Patients with Secondary Progressive Multiple Sclerosis

Study on the Effects of Siponimod for Patients with Secondary Progressive Multiple Sclerosis

Study on NECVAX-NEO1 and Paclitaxel Albumin-Bound for Patients with Triple-Negative Breast Cancer

Study on NECVAX-NEO1 and Paclitaxel Albumin-Bound for Patients with Triple-Negative Breast Cancer

Study on the Effectiveness and Safety of Naxitamab for Patients with Refractory Ewing's Sarcoma

Study on the Effectiveness and Safety of Naxitamab for Patients with Refractory Ewing's Sarcoma

Study of Atezolizumab, Vinorelbine, and Cyclophosphamide for Patients with Advanced Triple Negative Breast Cancer Previously Treated with Anti-PD-L1/PD-1

Study of Atezolizumab, Vinorelbine, and Cyclophosphamide for Patients with Advanced Triple Negative Breast Cancer Previously Treated with Anti-PD-L1/PD-1

Study on Intestifix for Treating Immune Activation in Patients with Liver Cirrhosis and Ascites

Study on Intestifix for Treating Immune Activation in Patients with Liver Cirrhosis and Ascites

Study on Darbepoetin Alfa for Reducing Brain Injury in Newborns with Perinatal Arterial Ischemic Stroke

Study on Darbepoetin Alfa for Reducing Brain Injury in Newborns with Perinatal Arterial Ischemic Stroke